Page last updated: 2024-11-05

tolbutamide and Leprosy

tolbutamide has been researched along with Leprosy in 2 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GOKHALE, BB1
KOTNIS, MG2
KASBEKAR, PV1
MARATHE, SV1
Ranade, SN1
Joshi, PB1
Deshpande, SM1
Apte, AN1

Other Studies

2 other studies available for tolbutamide and Leprosy

ArticleYear
LEPROTIC REACTIONS AND ANABOLIC AND ANTI-DIABETIC DRUGS.
    Leprosy review, 1964, Volume: 35

    Topics: Anabolic Agents; Calcification, Physiologic; Diabetes Mellitus; Humans; Leprosy; Liver Function Test

1964
Tolrivizin in the treatment of trophic ulcers in leprosy.
    Indian journal of dermatology, 1965, Volume: 11, Issue:1

    Topics: Adult; Female; Humans; Leprosy; Male; Middle Aged; Tolbutamide

1965